matrifen 100 mikrogram/time depotplastre
takeda pharma a/s - fentanyl - depotplastre - 100 mikrogram/time
matrifen 25 mikrogram/time depotplastre
takeda pharma a/s - fentanyl - depotplastre - 25 mikrogram/time
matrifen 50 mikrogram/time depotplastre
takeda pharma a/s - fentanyl - depotplastre - 50 mikrogram/time
matrifen 75 mikrogram/time depotplastre
takeda pharma a/s - fentanyl - depotplastre - 75 mikrogram/time
natriumklorid isotonisk "dak" 9 mg/ml injektionsvæske, opløsning
takeda pharma a/s - natriumchlorid - injektionsvæske, opløsning - 9 mg/ml
vepicombin novum 1,5 mill. ie filmovertrukne tabletter
takeda pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1,5 mill. ie
vepicombin novum 1 mill. ie filmovertrukne tabletter
takeda pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie
pantecta control
takeda gmbh - pantoprazol - gastroøsofageal tilbagesvaling - proton pumpe hæmmere - kortvarig behandling af reflukssymptomer (f.eks. halsbrand, syreregurgitation) hos voksne.
pantoloc control
takeda gmbh - pantoprazol - gastroøsofageal tilbagesvaling - proton pumpe hæmmere - kortvarig behandling af reflukssymptomer (f.eks. halsbrand, syreregurgitation) hos voksne.
ceprotin
takeda manufacturing austria ag - humant protein c - purpura fulminans; protein c deficiency - antitrombotiske midler - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.